Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Flavonoids are a diverse group of plant-derived polyphenolic compounds known for their antioxidant, anti-inflammatory, and vascular-protective properties. There is scientific evidence to suggest that flavonoids may be beneficial in the management of diabetic retinopathy, although most of this evidence is preclinical or from small human studies rather than large-scale randomized controlled trials. Diabetic retinopathy is characterized by microvascular damage in the retina due to chronic hyperglycemia, oxidative stress, and inflammation. Flavonoids (such as quercetin, rutin, and hesperidin) have been shown in animal models and in vitro studies to reduce oxidative stress, inhibit inflammation, and improve endothelial function—all factors implicated in the pathogenesis of diabetic retinopathy.

A few small clinical trials and observational studies have reported that flavonoid supplementation may slow the progression of retinal microvascular damage and reduce retinal edema in people with diabetes. For example, some studies using standardized flavonoid extracts (like diosmin and hesperidin) have demonstrated improved retinal blood flow and decreased capillary leakage. However, the overall quality of human evidence is moderate, with limited sample sizes and varying formulations and dosages.

In summary, while there is a plausible biological rationale and some supportive data from preclinical and early clinical studies, robust clinical evidence is still lacking, and further research is needed to firmly establish the efficacy and optimal dosing of flavonoids for diabetic retinopathy.

More about Flavonoid
More about Diabetic Retinopathy

Other ingredients used for Diabetic Retinopathy

Other health conditions supported by Flavonoid

Products containing Flavonoid